|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.
The latest price target for AbbVie (NYSE: ABBV) was reported by SVB Leerink on August 20, 2021. The analyst firm set a price target for 148.00 expecting ABBV to rise to within 12 months (a possible 35.27% upside). 12 analyst firms have reported ratings in the last year.
The stock price for AbbVie (NYSE: ABBV) is $109.41 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for AbbVie. The last dividend paid out to investors was $0.05 on October 14, 2021.
AbbVie’s $Q3 earnings are confirmed for after-market on $October 29, 2021.
There is no upcoming split for AbbVie.
AbbVie is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.